Silo Pharma, Inc.

Nasdaq:SILO

Pharmaceutical Preparations·SARASOTA, FL

A silo is a structure for storing bulk materials.

CEO

Weisblum Eric

CFO

Ryweck Daniel E.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/9/25	→
10-K	FY 2024	12/31/24	3/28/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

News (8-K)

80 shown

Filed	Type	Description
2/23/26	Other	Unregistered Sales of Equity Securities	→
12/29/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
10/24/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/1/25	Agreement	Entry into a Material Definitive Agreement	→
8/5/25	Other	Other Events	→
7/29/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

37 shown

Filed	Form	Description
11/26/25	424B3	424B3	→
10/29/25	S-1	REGISTRATION STATEMENT	→
10/1/25	424B5	PROSPECTUS SUPPLEMENT	→
9/5/25	ARS	ARS	→
8/18/25	424B5	PROSPECTUS SUPPLEMENT	→
5/16/25	424B4	424B4	→
↓

Filing History(348 filings)

TypeDateAccessionPeriodSize

8-K

Feb 23, 2026

0001213900-26-019384CURRENT REPORT

Feb 20, 2026

195.7 KB

SCHEDULE 13G/A

Feb 17, 2026

0001193125-26-053479

—

33.0 KB

SCHEDULE 13G/A

Feb 13, 2026

0001213900-26-016528

—

12.7 KB

SCHEDULE 13G/A

Feb 13, 2026

0001213900-26-016071

—

6.9 KB

8-K

Dec 29, 2025

0001213900-25-125838CURRENT REPORT

Dec 24, 2025

186.8 KB

Dec 16, 2025

0001213900-25-122429

Dec 15, 2025

6.1 KB

EFFECT

Nov 26, 2025

9999999995-25-003402

—

1.9 KB

424B3

Nov 26, 2025

0001213900-25-115503PROSPECTUS

—

407.2 KB

Nov 21, 2025

0001213900-25-113743

Nov 20, 2025

6.1 KB

Nov 20, 2025

0001213900-25-113104

Nov 18, 2025

7.2 KB

SCHEDULE 13G

Nov 14, 2025

0001193125-25-282676

—

32.4 KB

10-Q

Nov 13, 2025

0001213900-25-110006QUARTERLY REPORT

Sep 30, 2025

5.9 MB

SCHEDULE 13G/A

Nov 7, 2025

0001213900-25-107728

—

13.2 KB

S-1

Oct 29, 2025

0001213900-25-103188REGISTRATION STATEMENT

—

487.8 KB

8-K

Oct 24, 2025

0001213900-25-102222CURRENT REPORT

Oct 24, 2025

215.8 KB

SCHEDULE 13G

Oct 3, 2025

0001213900-25-096008

—

7.0 KB

8-K

Oct 1, 2025

0001213900-25-094711CURRENT REPORT

Sep 29, 2025

793.0 KB

424B5

Oct 1, 2025

0001213900-25-094384PROSPECTUS SUPPLEMENT

—

486.0 KB

DEFA14A

Sep 5, 2025

0001213900-25-085128DEFINITIVE ADDITIONAL MATERIALS

—

3.1 MB

ARS

Sep 5, 2025

0001213900-25-085125ARS

Dec 31, 2024

777.4 KB

DEF 14A

Sep 5, 2025

0001213900-25-085119DEFINITIVE PROXY STATEMENT

Oct 24, 2025

4.2 MB

PRE 14A

Aug 25, 2025

0002077096-25-000053PRELIMINARY PROXY STATEMENT

Aug 25, 2025

3.8 MB

424B5

Aug 18, 2025

0001213900-25-077936PROSPECTUS SUPPLEMENT

—

956.5 KB

10-Q

Aug 13, 2025

0001213900-25-075693QUARTERLY REPORT

Jun 30, 2025

5.2 MB

SCHEDULE 13G/A

Aug 12, 2025

0001213900-25-075089

—

12.3 KB

25 filings shown

Silo Pharma, Inc.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(348 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
9/5/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
9/5/25	DEF 14A	DEFINITIVE PROXY STATEMENT	→
8/25/25	PRE 14A	PRELIMINARY PROXY STATEMENT	→
11/15/24	DEFR14A	DEFR14A	→
11/8/24	DEFA14A	DEFA14A	→
9/18/24	DEFA14A	ADDITIONAL DEFINITIVE SOLICITING MATERIALS.	→
↓

Filed	Form	Description
12/16/25	4	4	→
11/21/25	4	4	→
11/20/25	4	4	→
5/28/25	4	4	→
5/27/25	4	4	→
5/27/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/26/25	EFFECT	EFFECT	→
11/14/25	SCHEDULE 13G	SCHEDULE 13G	→
11/7/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓